Subscribe to Our Newsletter

Success! Now Check Your Email

To complete Subscribe, click the confirmation link in your inbox. If it doesn’t arrive within 3 minutes, check your spam folder.

Ok, Thanks

Clinical Trials

A collection of 15 Posts

Field Medical Presents Positive 6-Month First-in-Human Data for PFA System in Ventricular Tachycardia post image

Field Medical Presents Positive 6-Month First-in-Human Data for PFA System in Ventricular Tachycardia

Sapu Nano Initiates Phase 1 Clinical Trial for Novel IV Deciparticle™ Everolimus in Oncology post image

Sapu Nano Initiates Phase 1 Clinical Trial for Novel IV Deciparticle™ Everolimus in Oncology

Spruce Biosciences' Sanfilippo Syndrome B Therapy Gains FDA Breakthrough Designation, Boosting Stock Value post image

Spruce Biosciences' Sanfilippo Syndrome B Therapy Gains FDA Breakthrough Designation, Boosting Stock Value

uniQure's AMT-130 Gene Therapy Shows Breakthrough Efficacy in Huntington's Trial, Accelerating FDA Pathway post image

uniQure's AMT-130 Gene Therapy Shows Breakthrough Efficacy in Huntington's Trial, Accelerating FDA Pathway

Diethylene Glycol in Cough Syrups: Unpacking the Regulatory Failures and Patient Safety Implications post image

Diethylene Glycol in Cough Syrups: Unpacking the Regulatory Failures and Patient Safety Implications

Kexing Biopharm Secures Marketing Approvals for Sorafenib Generic in Egypt and Peru post image

Kexing Biopharm Secures Marketing Approvals for Sorafenib Generic in Egypt and Peru

UTR Therapeutics Publishes Landmark Preclinical Data, Advances c-MYC Targeting Drug Towards First-in-Human Trials post image

UTR Therapeutics Publishes Landmark Preclinical Data, Advances c-MYC Targeting Drug Towards First-in-Human Trials

NeOnc Technologies Advances Brain Cancer Drug NEO212 to Phase II Clinical Trial post image

NeOnc Technologies Advances Brain Cancer Drug NEO212 to Phase II Clinical Trial

BioVersys Reports Strong H1 2025 Progress in Antibacterial Drug Development post image

BioVersys Reports Strong H1 2025 Progress in Antibacterial Drug Development

Servier acquires potential treatment for Fragile X syndrome, the most common genetic cause of autism spectrum disorder post image

Servier acquires potential treatment for Fragile X syndrome, the most common genetic cause of autism spectrum disorder

BioMarin Announces Positive Phase 3 Data for PALYNZIQ in Adolescent PKU Treatment post image

BioMarin Announces Positive Phase 3 Data for PALYNZIQ in Adolescent PKU Treatment

Single Dose of Pharmaceutical LSD Shows Promise in Relieving Anxiety for Months post image

Single Dose of Pharmaceutical LSD Shows Promise in Relieving Anxiety for Months